THARISA PLC |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.75 ZAR | +1.29% |
|
+0.25% | +4.24% |
| 04-10 | Tharisa plc Reports Operating Results for the Second Quarter and Six Months Ended March 31, 2024 | CI |
| 04-10 | Tharisa performs "well" in second quarter as platinum price stabilises | AN |
Strengths
- Its low valuation, with P/E ratio at 68.18 and 115.81 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
- The company is one of the most undervalued, with an "enterprise value to sales" ratio at 7.18 for the 2024 fiscal year.
- The company's share price in relation to its net book value makes it look relatively cheap.
- Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- The company's earnings growth outlook lacks momentum and is a weakness.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
- Most analysts agree on a negative opinion with regard to the stock. Indeed, the average consensus issues recommendations to underperform or sell.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Non-Gold Precious Metals & Minerals
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +4.24% | 251M | - | ||
| -11.34% | 2.58B | A- | ||
| -21.90% | 1.19B | - | - | |
| +2.33% | 245M | C- | ||
| -8.55% | 226M | - | ||
| +25.33% | 141M | - | - |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
-
Divergence of Target Price
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- THA Stock
- Ratings Tharisa plc
